NCT07632612 Comparing the Effectiveness of Tensioner Vs Slider Neurodynamic Techniques in Patients With Sciatica
| NCT ID | NCT07632612 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ibadat International University, Islamabad |
| Condition | Sciatica |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-06-03 |
| Primary Completion | 2026-09-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-06-03 with a primary completion date of 2026-09-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
objective of this randomized controlled trial is to examine the efficacy of both tensioner and slider neurodynamic approaches in patients suffering from sciatica. This study seeks to establish which approach is more efficacious in alleviating pain intensity, disability functional, and mobility. The results of this study will assist physical therapists in making an informed decision on the type of neurodynamic therapy for their patients.
Eligibility Criteria
Inclusion Criteria: * Patients with radicular pain persisting for 12 weeks to 1 year, with no acute episode in the last 4 weeks * Unilateral symptoms radiating below the buttock to thigh, knee, or lower leg * Positive Slump Test * Positive Straight Leg Raise (SLR) test above 45° * Functional limitation during activities such as walking or lifting Exclusion Criteria: * BMI \< 20 kg/m² or \> 30 kg/m² * Previous history of spinal surgery * Presence of red flags (significant motor/sensory loss, altered reflexes, or bowel/bladder dysfunction) * Peripheral neuropathy * History of vertebral fracture or significant spinal/limb trauma * Systemic diseases (e.g., diabetes mellitus, cardiovascular, or renal disease) * Progressive neurological deficits (motor weakness, sensory loss, reflex changes) * Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07632612 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 50 Years, studying Sciatica. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07632612 currently recruiting?
Yes, NCT07632612 is actively recruiting participants. Contact the research team at sojlabashir@gmail.com for enrollment information.
Where is the NCT07632612 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT07632612 clinical trial?
NCT07632612 is sponsored by Ibadat International University, Islamabad. The trial plans to enroll 80 participants.